16:02 Dec 20
Glenmark Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Glenmark Pharmaceuticals Ltd.
Industry Pharmaceuticals
16:02 Dec 20
Quality
19/100
Low Financial Strength
Valuation
12/100
Expensive Valuation
Technical
57/100
Technically Neutral
Strength
5
Weakness
7
Opportunity
1
Threats
0
0.16 %
Dividend Yield
43.50K
Market Cap (Cr)
48.06
RSI
46.65 %
Promoter Holding
-12.71 %
Net Profit Margin
| Client | Date | Avg Price | Qty | Value(Cr) | Action |
|---|
Download Our App On:
